Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
The Pfizer/BioNTech bivalent COVID-19 vaccine (both Original and Omicron BA.4/BA.5) is already FDA-authorized under an EUA for use in individuals 12 years old and above as a single booster dose ...
30, children were 26.7% of reported weekly Covid-19 cases. The FDA has set a date of Oct. 26 for outside advisers to meet and discuss the Pfizer application, making it possible for kids to begin ...
The federal Centers for Disease Control and Prevention has added the Covid-19 vaccine ... including the bivalent booster, have emergency-use authorization for children 6 months of age and older, but ...
Now it's in a COVID-19 crisis. "These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and ...
and the U.S. Food and Drug Administration (FDA) about a possible “safety signal” for the Pfizer-BioNTech Covid-19 bivalent booster vaccine. Not surprisingly the chatter has been a bit like the ...
The COVID vaccine may ... given with a high-dose flu shot, primarily in seniors over 85, according to new FDA analyses. The ...
“We appreciate the FDA's timely review and encourage individuals who intend to get their flu shot to also get their updated Covid-19 vaccine at the same time.” ...
Aiming to provide additional protection for Americans against the coronavirus over the upcoming flu season, the FDA ... The new shots have been updated to better protect against a more recent omicron ...
The FDA announcement did mention studies that compared the use of bivalent boosters and ... she receives a Moderna Omicron Covid-19 booster ... [+] vaccine on February 17 in a clinical study ...
Last fall, U.S. health officials authorized new COVID-19 booster shots designed ... on whether a second bivalent booster dose is needed right now. However, the FDA recently proposed switching ...
The FDA's proposal follows the European regulator's backing last month for the use of bivalent COVID shots for primary vaccination.